Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

T-cell immunotherapy: looking forward.

Autor: Corrigan-Curay J; Office of Science Policy, Office of the Director, National Institutes of Health, Bethesda, Maryland, USA., Kiem HP; Fred Hutchinson Cancer Research Center, Seattle, Washington, USA., Baltimore D; California Institute of Technology, Pasadena, California, USA., O'Reilly M; Office of Science Policy, Office of the Director, National Institutes of Health, Bethesda, Maryland, USA., Brentjens RJ; Memorial Sloan-Kettering Cancer Center, New York, New York, USA., Cooper L; MD Anderson Cancer Center, Houston, Texas, USA., Forman S; City of Hope, Duarte, California, USA., Gottschalk S; Baylor College of Medicine, Houston, Texas, USA., Greenberg P; Fred Hutchinson Cancer Research Center, Seattle, Washington, USA., Junghans R; Roger Williams Medical Center, Providence, Rhode Island, USA., Heslop H; Baylor College of Medicine, Houston, Texas, USA., Jensen M; University of Washington, Seattle, Washington, USA., Mackall C; National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA., June C; Abramson Cancer Center, University of Pennsylvania, Philadelphia, Pennsylvania, USA., Press O; Fred Hutchinson Cancer Research Center, Seattle, Washington, USA., Powell D; Abramson Cancer Center, University of Pennsylvania, Philadelphia, Pennsylvania, USA., Ribas A; David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, California, USA., Rosenberg S; National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA., Sadelain M; Memorial Sloan-Kettering Cancer Center, New York, New York, USA., Till B; Fred Hutchinson Cancer Research Center, Seattle, Washington, USA., Patterson AP; Office of Science Policy, Office of the Director, National Institutes of Health, Bethesda, Maryland, USA., Jambou RC; Office of Science Policy, Office of the Director, National Institutes of Health, Bethesda, Maryland, USA., Rosenthal E; Office of Science Policy, Office of the Director, National Institutes of Health, Bethesda, Maryland, USA., Gargiulo L; Office of Science Policy, Office of the Director, National Institutes of Health, Bethesda, Maryland, USA., Montgomery M; Office of Science Policy, Office of the Director, National Institutes of Health, Bethesda, Maryland, USA., Kohn DB; David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, California, USA.

Publikováno v: Molecular therapy : the journal of the American Society of Gene Therapy [Mol Ther] 2014 Sep; Vol. 22 (9), pp. 1564-74.

Complete sequence of the major nucleocapsid protein gene of human parainfluenza type 3 virus: comparison with other negative strand viruses.

Autor: Jambou RC, Elango N, Venkatesan S, Collins PL

Publikováno v: The Journal of general virology [J Gen Virol] 1986 Nov; Vol. 67 ( Pt 11), pp. 2543-8.